Penn Life Sciences develops and manufactures FDA-approved medicines, with a focus on sterile drug production to address shortages of generic sterile medicines in the United States. Founded to respond to gaps in domestic aseptic production, the company operates a 270,000-square-foot manufacturing, warehouse, and laboratory facility with stated capacity for 400 million vials, bottles, and syringes annually.
FDA guidelines
Compliance program
DEA guidelines
Compliance program
DEP guidelines
Compliance program
The Vanguard Utility CorporationBased in Apex, North Carolina, The Vanguard Utility develops and manufactures sterile liquid and injectable medicines aimed at easing persistent drug shortages. Its planned U.S. facility uses automated Blow-Fill-Seal technology to form, fill, and seal medicines in one sterile process, while its Global Pharmacy Reserve and Pharmaceutical Reserve Network extend access through unit-dose supply and partnerships with manufacturers. The company is an operational subsidiary of Apiject focused on rebuilding domestic capacity for essential medicines.NEWTOWN, PA
Amstergen Life Sciences LLCAmstergen Life Sciences LLC is a Pennsylvania-based pharmaceutical company specializing in sterile oncology and non-oncology products, including injectables and ophthalmics. The company focuses on developing, manufacturing, and marketing generic pharmaceutical products and offers contract manufacturing services.WARMINSTER, PA
AquabilitiSince 2005, Aquabiliti has been a wholly American-owned manufacturer serving pharmaceutical, biotechnology, and medical-device customers from facilities in Pennsylvania and Tennessee. Known for keeping single-use system design and production in-house, the company develops tailored sterile water and process solutions for regulated life-sciences workflows. Its U.S. facilities are ISO 13485 certified, with the Pennsylvania operation also housing a 60,000-square-foot cGMP-compliant aqueous-solutions facility.EMIGSVILLE, PA
Epic PharmaEpic Pharma began operations in 2008 after acquiring the former Sandoz facility in Laurelton, New York, and has built its identity around making affordable generic prescription medicines for the U.S. healthcare community. Its 110,000-square-foot, FDA-approved plant also supports contract manufacturing for pharmaceutical partners, with development and production carried out under established regulatory controls.LAURELTON, NY